Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 35-45, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085390
3.
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Br J Cancer
; 119(3): 330-338, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955134
4.
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 46-47, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335272
5.
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Front Pharmacol
; 13: 946348, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105223
6.
Cul3 regulates cytoskeleton protein homeostasis and cell migration during a critical window of brain development.
Nat Commun
; 12(1): 3058, 2021 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031387
7.
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
Cancers (Basel)
; 13(5)2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33802395
8.
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer.
Cancers (Basel)
; 12(12)2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33352957
9.
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.
Cancer Lett
; 459: 1-12, 2019 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150822
10.
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.
Neoplasia
; 20(3): 280-288, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29466768
11.
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Eur J Cancer
; 79: 214-225, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28525846
12.
A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 23(24): 7621-7632, 2017 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28972047
13.
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.
Clin Cancer Res
; 23(9): 2213-2222, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27663594
14.
Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.
Cancer Lett
; 362(2): 218-28, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862976
Resultados
1 -
14
de 14
1
Próxima >
>>